Search NEL Online

Journal Article 2006; 27(1-2): 277-280 PubMed PMID: 16648799 Citation  Keywords:  Adult, Carbohydrate Metabolism:physiology, Diabetes, Gestational:blood, Diet, Diabetic, Fatty Acids, Nonesterified:blood, Female, Fetal Blood:chemistry, Fetal Development:physiology, Humans, Hypoglycemic Agents:therapeutic use, Insulin:therapeutic use, Pr.   

AIM OF THE STUDY: The investigation of the influence of maternal serum free fatty acids (FFA) levels on the course of gestational diabetes mellitus (GDM).

MATERIAL AND METHODS: On the basis of GDM diagnosis 52 diabetic and 39 non-diabetic pregnant women were recruited to the study. Treatment modalities for diabetic group included diet alone (GDM1; n-36) or a combination of insulin and diet (GDM2; n-16). Maternal serum free fatty acids were measured before treatment, after 4 weeks therapy, during delivery and in umbilical cord blood.

RESULTS: Plasma levels of FFA were higher in GDM pregnant women treated later only by diet compare with GDM patients required later insulin and non-diabetic gravidas. In GDM diet treated group plasma FFA levels progressively decreased with treatment duration. The plasma FFA levels in umbilical cord blood did not differ between the study groups. We found a positive correlation between maternal venous and umbilical cord blood concentration of free fatty acids. Maternal FFA levels positively correlated with neonatal births weight.

CONCLUSION: Elevated plasma FFA levels are associated with GDM and can influence fetal growth. Early and intensified GDM treatment may decrease the level of circulating fatty acids....

Read abstract

Journal Article 2006; 27(1-2): 263-266 PubMed PMID: 16648794 Citation  Keywords:  Animals, Injections, Intraperitoneal, Lactic Acid:blood, Male, Melatonin:pharmacology, Rats, Rats, Sprague-Dawley, Swimming:psychology, Zinc:blood,.   

OBJECTIVE: The objective of the present study is to examine the effect on melatonin supplementation on plasma lactate levels and its relation with zinc in rats subjected to acute swimming exercise.

METHODS: Thirty adult male rats of Spraque-Dawley species were allocated to 3 groups, each containing an equal number of rats: general control group which was not subjected to any procedure (Group 1), the group which was subjected to 30 minutes acute swimming exercise (Group 2), and the group which was subjected to 30 minutes acute swimming exercise after 4-week intraperitoneal (i.p.) melatonin (3 mg/kg/day) supplementation. Lactate and zinc levels in the plasma were studied in the blood samples taken from the experimental animals by decapitation method.

RESULTS: The animals in the control group, which was not subjected to any procedure (group 1), had higher lactate levels than those in groups 2 and 3 (p<0,05). Lactate levels in the swimming group supplemented with melatonin (group 3) were lower than those in group 2 (swimming group) (p<0,05). The highest plasma zinc levels were obtained in the melatonin-supplemented swimming group (group 3) (p<0,05). Group 2 (swimming control) had the lowest plasma zinc levels (p<0,05).

CONCLUSION: Results of the study demonstrate that melatonin supplementation to rats subjected to acute swimming exercise reduces lactate levels, thereby delaying exhaustion. Increased zinc levels may be mediating this melatonin effect....

Read abstract

Journal Article 2006; 27(1-2): 198-202 PubMed PMID: 16648793 Citation  Keywords:  Adolescent, Adult, Female, Gonadal Steroid Hormones:blood, Humans, Kidney:diagnostic imaging, Kidney Transplantation:physiology, Menstrual Cycle:physiology, Ovary:physiology, Reproduction:physiology, Ultrasonography,.   

OBJECTIVES: End-stage renal failure is associated with amenorrhaea and extremely reduced fertility. After successful kidney transplantation restoration of menstrual function is observed. The aim of the study was to investigate ovarian function and menstrual cycles in kidney-transplanted women of reproductive age.

MATERIALS AND METHODS: 55 ovarian cycles in kidney transplanted women, aged 18-40 years, being one to five years after transplantation, were analyzed and compared with 50 cycles of healthy women. The duration of the cycles as well as FSH, LH, estradiol, progesterone, prolactin and testosterone serum concentrations were monitored. Simultaneously the presence of ovulation was evaluated with repeated sonographic examinations.

RESULTS: Regular menstrual cycles were observed in 72.7% of kidney transplanted women. The rates of ovulatory cycles were similar in the study group and the control: 65% and 70% respectively. Mean estradiol level in the follicular phase of the cycle was significantly higher in transplant patients (205.9, SD 160.22 vs 135.9 pg/ml, SD 68.34 in the control). Significantly lower levels of progesterone (13.2 ng/ml, SD 14.2 vs 26.7 ng/ml, SD 14.1 in the control) and testosterone were observed in kidney recipients. Other hormonal parameters did not differ significantly between the groups.

CONCLUSIONS: The rate of ovulatory cycles in regularly menstruated kidney transplanted patients is similar to that of healthy women. Similar serum FSH, LH and PRL concentrations as well as increased levels of estrogens are observed in kidney graft recipients in comparison to healthy non-recipients. Increased levels of estrogens put that group of patients at risk of gynecological pathologies....

Read abstract

Case Reports 2006; 27(1-2): 13-15 PubMed PMID: 16648792 Citation  Keywords:  Acidosis:etiology, Brain Edema:etiology, Child, Preschool, Humans, Hydronephrosis:congenital, Magnetic Resonance Imaging, Male, Metabolic Diseases:complications, Nephrectomy, Reye Syndrome:complications, Stroke:etiology,.   

: Three years old boy with developmental renal dysplasia was hit as newborn child by attack of cerebral edema with metabolic disturbances (hypoglycemia, hypophosphatemia, ketoacidosis and with hypocoagulation state) and was classified as child at risk in the pediatric evidence. In the third year of the age he went through nephrectomy and after the operation, the similar metabolic disturbances occurred (hypoglycemia, ketoacidosis, derangement of the metabolic situation). Cerebral edema and the metabolic stroke developed. Reye's-like syndrome was considered and serious functional disturbances of basal ganglia and brain-stem structure were observed....

Read abstract

Journal Article 2006; 27(1-2): 267-270 PubMed PMID: 16648790 Citation  Keywords:  Animals, Dietary Supplements, Injections, Intraperitoneal, Lactic Acid:blood, Male, Rats, Rats, Sprague-Dawley, Swimming:physiology, Testosterone:blood, Zinc:blood,.   

OBJECTIVE: There is fairly scarce information about the effects of zinc, an essential trace element, on performance. Studies concerned with the relation between zinc and exercise mostly concentrate on the distribution of this element in the body in response to exercise. The objective of the present study is to explore how zinc supplementation affects testosterone levels and its relation with lactate in rats subjected to acute swimming exercise.

MATERIALS AND METHODS: Thirty adult male rats of Sprague-Dawley species were equally allocated to 3 groups. Group 1: Control. Group 2: Group subjected to 30-minute acute swimming exercise. Group 3: Group supplemented with intraperitoneal (i.p.) zinc (3 mg/kg day) for 4 weeks and subjected to 30-minute swimming exercise. Blood samples collected from all experimental animals by decapitation method were analyzed to determine free and total testosterone and lactate levels in the plasma.

RESULTS: Group 3 had the highest free and total testosterone levels, followed by Group 1 and Group 2. The highest lactate levels were found in Group 2 and the levels in Group 3 were higher than those in Group 1.

CONCLUSION: Results of the study demonstrate that zinc supplementation leads to a significant increase in testosterone levels and a significant decrease in lactate levels. In conclusion, physiological doses of zinc supplementation can be useful for performance....

Read abstract

Journal Article 2006; 27(1-2): 149-152 PubMed PMID: 16648787 Citation  Keywords:  Body Height:physiology, Child, Female, Growth:drug effects, Growth Hormone:therapeutic use, Human Growth Hormone:deficiency, Humans, Male, Parents, Prognosis,.   

INTRODUCTION: Parental height is the most important identifiable factor influencing final height (FH) of children with growth hormone (GH) deficiency (GHD), treated with GH.

AIM: Assessment of FH of patients with GHD--classified into familial short stature (FSS) and non-familial short stature (non-FSS) according to parentally adjusted deficit of height.

PATIENTS AND METHODS: The analysis comprised 101 patients (76 boys) with childhood-onset GHD. Final height was compared with patients' height before GH therapy, predicted adult height (PAH) and target height (TH).

RESULTS: Both GH peak in stimulating tests and height standard deviation score (SDS) before the therapy were significantly lower in non-FSS than in FSS. Target height was significantly lower in FSS than in non-FSS. Parentally-adjusted deficit of height was significantly more profound in non-FSS than in FSS. The prognosis of adult height was very similar in both groups of patients, being significantly worse in non-FSS than in FSS while corrected by TH. The absolute FH was similar in FSS and non-FSS, being, however, significantly lower in non-FSS than in FSS while corrected by TH. Improvement of height was significantly better in non-FSS than in FSS. In both groups, FH SDS was significantly better than height SDS before the therapy (H0SDS). In FSS group, PAH was similar to TH, moreover, FH corresponded to both PAH and TH. In non-FSS group FH was significantly higher than PAH, but both FH and PAH were significantly lower than TH.

CONCLUSIONS: 1) Growth hormone therapy was more effective in the patients with non-FSS than in those with FSS. 2) Parentally-adjusted deficit of height is an important prognostic factor of GH therapy effectiveness....

Read abstract

Journal Article 2006; 27(1-2): 105-113 PubMed PMID: 16648786 Citation  Keywords:  Adrenergic beta-Agonists:pharmacology, Adrenergic beta-Antagonists:pharmacology, Albuterol:pharmacology, Algorithms, Alprenolol:pharmacology, Animals, Animals, Newborn, Body Mass Index, Body Weight:drug effects, Female, Isoproterenol:pharmacology, Male, M.   

BACKGROUND: beta-adrenergic ligands have been shown to influence sexual differentiation of the brain. In the present study we document that short postnatal treatment with beta-adrenergic agonists or antagonists may permanently reverse the morphological sex of the brain, as judged by the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA). Female rats treated by beta(2)-adrenergic stimulating ligands exhibit an increased, male type SDN-POA volume while male rats treated by beta1-adrenergic antagonists show a decreased, female type of SDN-POA volume.

OBJECTIVES: To analyze the volume of SDN-POA of adult rats after postnatal administration of betaadrenergic ligands.

METHODS: From the second day of life, over 5 consecutive days, all the neonates were injected subcutaneously with the following drugs: isoproterenol, salbutamol, metoprolol alprenolol or saline. SDN-POA volumes were estimated planimetrically on serial brain slides.

RESULTS: In male rats the mean volume of SDN-POA was 9.97 +/- 1.66 x 10(-3) mm(3), in female rats the respective volume reached 4.02 +/- 1.26 x 10(-3) mm(3) only and was 2.5 times lower, the difference being highly statistically significant. Postnatal administration of isoproterenol remained without effect in male rats but diminished the SDN-POA volume in female rats, thus increasing the sexual dimorphism. The disappearance of sexual dimorphism was noted in rats treated postnatally with salbutamol. This effect was due to the increase in SDN-POA volumes in female rats, up to 9.81 +/- 2.64 x 10(-3) mm(3), the levels approaching the male type of POA differentiation. Postnatal alprenolol treatment influenced the sexual dimorphism of the brain by decreasing the SDN-POA volume reached by adult males. In fact, in rats treated postnatally with alprenolol, the volume of the nucleus reached only 4,44 +/- 1,61 x 10(-3) mm(3), being not statistically different from female nuclei. The effect of metoprolol pretreatment was similar to alprenolol. Male volumes of SDN-POA were restored both by isoproterenol and salbutamol in metoprolol pretreated rats and by isoproterenol only in alprenolol treated rats.

CONCLUSION: It appears that inhibition of beta(1)-adrenergic pathway is able to shut off the physiologic mechanisms of male differentiation of SDN-POA, and the subsequent beta(2)-adrenergic stimulation activates an alternative mechanism of masculinization. beta(2)-adrenergic signal is able to masculinize rat preoptic area in females as well. From the presented data it may be concluded that beta adrenoreceptors participate in sexual differentiation of preoptic area in rats and the modulation of their activity in postnatal period permanently influences the morphology of the sexually differentiated nucleus of the preoptic area....

Read abstract

Comparative Study 2006; 27(1-2): 85-88 PubMed PMID: 16648782 Citation  Keywords:  Adolescent, Adult, Aged, Anticonvulsants:adverse effects, Carbamazepine:adverse effects, Cardiovascular Diseases:blood, Epilepsy:blood, Female, Folic Acid:blood, Humans, Immunoassay, Luminescence, Male, Middle Aged, Phenytoin:adverse effects, Valproic Aci.   

PURPOSE: Previous studies showed an association between the blood levels of folate and vitamin B(12) and the risk for cardiovascular disease. The aim of this study is to investigate the effect of chronic use of phenytoin, carbamazepine or valproate monotherapy on the plasma levels of folate and B(12), and to compare folate and B(12) levels in epileptic patients with or without cardiovasular disorders.

METHODS: The study was conducted in the outpatient neurology clinic at Bahrain Defence Force (BDF) Hospital between January-July, 2005. Medical information was obtained by interviewing the patients and examining their hospital records. Blood folate and vitamin B(12) were measured by Immulite immunoanalysis assay using chemoluminescence.

RESULTS: A total of 26 consecutive outpatients (17 males, 9 females) were recruited in the study. Their mean age +/- SD was 38.2 +/- 20.1 year (range 15-77 year). Five (19.2%) had complex partial epilepsy and the remainder had tonic-clonic seizures. They had epilepsy for 15.7 +/- 8.1 years (range 2-35 years). Thirteen of them used phenytoin, nine carbamazepine and four used valproate. The duration of the treatment (years), dose (mg/day) and serum concentration (micromol/l) were 18.3 +/- 10.6, 376.9 +/- 180.4, 41.6 +/- 25.6, for phenytoin, 14.5 +/- 11.7, 422.2 +/- 175.0, 31.1 +/- 15.9 for carbamazepine and 18.3 +/- 6.3, 400, 567.7 +/- 78.1 for valproate, respectively. Eleven (42.3%) had established cardiovascular disorders such as hypertension, myocardial infarction or stroke. The mean level of plasma folate (12.94 +/- 6.76 ng/ml) and B12 (484.94 +/- 191.25 pg/ml) in epileptic patients with cardiovascular disorders compared to their values (11.27 +/- 5.84), (514.49 +/- 225.31) respectively in epileptics with no cardiovascular disorders were not statistically significant in the two groups.

CONCLUSION: In epileptic patients on chronic therapy with phenytoin, carbamazepine or valproate folate and B(12) levels were not different in patients with or without cardiovascular disorders....

Read abstract